Introduction
Toxocariasis is a zoonotic parasitic disease caused by larvae of Toxocara canis or Toxocara cati, which are intestinal nematodes of dogs and cats, respectively. Humans are accidental hosts, typically infected through ingestion of embryonated eggs from contaminated soil, food, or direct contact with infected animals.1 Once ingested, larvae hatch in the intestine, penetrate the intestinal wall, and migrate through various tissues, causing inflammation and granulomatous reactions.2
Toxocariasis presents in diverse clinical forms, including Visceral Larva Migrans (VLM), Ocular Larva Migrans (OLM), and covert or common toxocariasis, depending on the tissues involved.3 Early and accurate diagnosis is crucial for preventing severe complications such as blindness, encephalitis, or chronic organ damage. This article explores the clinical and laboratory diagnostic findings of toxocariasis, highlighting the challenges and advancements in its identification.
Clinical findings in toxocariasis
The clinical manifestations of toxocariasis vary widely, influenced by the intensity of infection, immune response, and organs involved. The disease ranges from asymptomatic or mild symptoms to severe systemic or localised complications.
Types of toxocariasis
Visceral Larva Migrans (VLM)
VLM is the most common manifestation of toxocariasis. It occurs when larvae migrate through internal organs, eliciting systemic and organ-specific symptoms.4
- Systemic symptoms: Patients typically present with fever, fatigue, and malaise
- Organ-specific symptoms: Hepatic involvement is frequent, leading to hepatomegaly and abdominal pain. Pulmonary symptoms, such as wheezing, cough, or bronchospasm, are also observed, mimicking asthma or pneumonia5
Ocular Larva Migrans (OLM)
OLM results from the migration of larvae to the eye. It commonly affects children and is often unilateral.6 Symptoms include blurred vision, photophobia, and eye pain. Ophthalmologic examination reveals retinal granulomas, strabismus, or uveitis.7 OLM can lead to irreversible visual impairment or blindness if left untreated.
Covert or common toxocariasis
This form is characterised by mild, non-specific symptoms, including abdominal pain, headache, and behavioral changes.8 It is often underdiagnosed due to its subtle presentation.
Neurotoxocariasis
Though rare, neurotoxocariasis can occur when larvae invade the central nervous system (CNS). Patients may present with seizures, encephalitis, or cognitive impairment.9
Risk factors for clinical presentation
Certain populations are at a higher risk of developing toxocariasis. Children, especially those in rural areas or with frequent exposure to dogs and cats, are more susceptible due to poor hygiene practices.10 Geographic and environmental factors, such as contaminated soil in tropical and subtropical regions, also play a significant role.11
Laboratory findings in toxocariasis
Laboratory investigations are essential for confirming the diagnosis, especially in cases with non-specific clinical presentations.
Blood tests
Eosinophilia
Persistent eosinophilia is a hallmark feature of toxocariasis, reflecting an immune response to larval antigens. It is more pronounced in VLM cases, with eosinophil counts often exceeding 30% of total leukocytes.12
Elevated total IgE levels
High levels of IgE are commonly observed, indicating an allergic or parasitic response. This finding, coupled with eosinophilia, strongly suggests a parasitic etiology.13
Other haematological changes
Mild anaemia, leukocytosis, and hypoalbuminemia may also be present in some cases, depending on the severity and chronicity of the disease.14
Serological tests
Enzyme-Linked Immunosorbent Assay (ELISA)
ELISA is the most widely used diagnostic tool for detecting Toxocara IgG antibodies. It has high sensitivity and specificity, particularly when excretory-secretory (TES) antigens from Toxocara larvae are used.15
Western blot
Western blot is used to confirm ELISA results, especially in cases of borderline or equivocal findings. It can differentiate Toxocara infections from other parasitic diseases that may cause cross-reactivity.16
Imaging techniques
Ultrasound and Computed Tomography (CT)
Imaging studies are valuable for detecting organ involvement in VLM cases.
- Ultrasound: Commonly used to visualise liver granulomas and assess hepatic involvement17
- CT Scans: Helpful for identifying pulmonary lesions or other organ abnormalities
Ophthalmologic examination
Ophthalmologic imaging, such as fundus photography, can reveal retinal granulomas, vitreous inflammation, or other ocular abnormalities indicative of OLM.18
Parasitological techniques
Parasitological methods, such as direct identification of larvae in tissue biopsies, are rarely used due to their invasiveness and low yield.19 However, they can provide definitive evidence of infection in challenging cases.
Differential diagnosis
Toxocariasis shares clinical and laboratory features with several other conditions, making differential diagnosis crucial.
Parasitic infections
- Ascariasis and strongyloidiasis can also present with eosinophilia and pulmonary symptoms 20.
- Schistosomiasis and echinococcosis may mimic hepatic involvement observed in toxocariasis.
Allergic conditions
- Asthma and eosinophilic granulomatosis with polyangiitis can resemble pulmonary toxocariasis
Systemic disorders
- Autoimmune diseases, such as systemic lupus erythematosus, may cause overlapping symptoms
Challenges in diagnosis
Asymptomatic or mildly symptomatic cases
Asymptomatic infections are often undiagnosed due to the absence of clinical indicators. In covert toxocariasis, mild symptoms may be attributed to other common conditions, delaying proper diagnosis and treatment.21
Cross-reactivity in serological tests
Serological tests, while reliable, can produce false-positive results due to cross-reactivity with antigens of other helminths, such as Ascaris lumbricoides or Strongyloides stercoralis.22
Limited availability of advanced diagnostic tools
Access to advanced serological and imaging techniques is often restricted in resource-limited settings, leading to underdiagnosis in endemic regions.23
Future directions and advances in diagnosis
To overcome existing challenges, ongoing research aims to develop more specific and accessible diagnostic methods.
Molecular methods
Polymerase chain reaction (PCR) techniques for detecting Toxocara DNA in blood or tissue samples show potential for improving diagnostic specificity and sensitivity.24
Advanced imaging techniques
Enhanced imaging modalities, such as high-resolution ocular imaging, are currently being explored for more accurate detection of OLM.25
Population-based screening
Serological surveys in endemic areas can help identify at-risk populations and guide public health interventions.26
Summary
Diagnosing toxocariasis requires a combination of clinical evaluation, serological testing, and imaging studies. Recognising the diverse clinical presentations and utilizing appropriate laboratory tools are essential for early and accurate diagnosis. Despite advances in diagnostic techniques, challenges such as asymptomatic cases and resource limitations persist. Future research focusing on molecular diagnostics and improved imaging technologies holds promise for enhancing diagnostic capabilities and patient outcomes.
By addressing these diagnostic challenges and increasing awareness, healthcare providers can better manage toxocariasis, preventing severe complications and improving quality of life for affected individuals.
References
- Pawlowski ZS. Toxocariasis in humans: clinical expression and treatment dilemma. J Helminthol. 2001;75(4):299–305.
- Lee AC, Schantz PM, Kazacos KR, Montgomery SP, Bowman DD. Epidemiologic and zoonotic aspects of ascarid infections in humans. Clin Microbiol Rev. 2010;23(2):265–302.
- Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003;16(2):265–72.
- Taylor MR, Keane CT, O’Connor P, Mulvihill E, Holland C. The expanded spectrum of toxocaral disease. Lancet. 1988;1(8587):692–5.
- Glickman LT, Schantz PM. Epidemiology and pathogenesis of zoonotic toxocariasis. Clin Microbiol Rev. 1981;9(3):233–42.
- Beaver PC. Larva migrans. Exp Parasitol. 1956;5(6):587–621.
- Shields JA, Shields CL. Ocular toxocariasis: a review. Surv Ophthalmol. 1984;28(5):361–81.
- Magnaval JF, Glickman LT, Dorchies P, Morassin B. Highlights of human toxocariasis. Korean J Parasitol. 2001;39(1):1–11.
- Finsterer J, Auer H. Neurotoxocarosis. Rev Inst Med Trop São Paulo. 2007;49(5):279–87.
- Chen J, Liu Q, Liu GH, et al. Toxocariasis: a silent threat with a progressive public health impact. Infect Dis Poverty. 2018;7(1):59.
- Hotez PJ, Wilkins PP. Toxocariasis: America’s most common neglected infection of poverty and a helminthiasis of global importance? PLoS Negl Trop Dis. 2009;3(3):e400.
- Woodhall DM, Eberhard ML, Parise ME. Neglected parasitic infections in the United States: toxocariasis. Am J Trop Med Hyg. 2014;90(5):810–3.
- Overgaauw PA, van Knapen F. Veterinary and public health aspects of Toxocara spp. Vet Parasitol. 2013;193(4):398–403.
- Rubinsky-Elefant G, Hirata CE, Yamamoto JH, Ferreira MU. Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol. 2010;104(1):3–23.
- Elefant GR, Shimizu SH, Sanchez MC, Jacob CM, Ferreira MU. A seroepidemiological survey of toxocariasis in southeastern Brazil. Rev Inst Med Trop São Paulo. 2006;48(4):211–5.
- Hamilton CM, Stafford P, Pinelli E, Holland CV. A murine model for Toxocara canis larval migration using GFP-expressing larvae. Parasitology. 2006;132(Pt 6):791–800.
- Holland CV, Hamilton CM. The significance of cerebral toxocariasis. In: Holland CV, Smith HV, editors. Toxocara: The enigmatic parasite. Wallingford: CABI Publishing; 2006. p. 259–72.
- Gillespie SH, Ramsay A, Beeching NJ. Principles and Practice of Clinical Parasitology. Chichester: Wiley; 2001.
- Stürchler D. Parasitic zoonoses in Europe: epidemiology of toxocarosis. Acta Trop. 1988;45(3):273–83.
- Fan CK, Lan HS, Hung CC, Chung WC, Liao CW. Seroepidemiology of Toxocara canis infection among mountain aboriginal adults in Taiwan. Am J Trop Med Hyg. 2004;71(2):216–21.
- Kwon NH, Kim HI, Kim BH, et al. Prevalence and risk factors of toxocariasis among healthy individuals. Korean J Parasitol. 2006;44(3):225–32.
- Pinelli E, Aranzamendi C. Toxocara infection and its association with allergic manifestations. Endocr Metab Immune Disord Drug Targets. 2012;12(1):33–44.
- Desowitz RS. Climate change and its impact on parasitology and parasitic diseases: an update. Southeast Asian J Trop Med Public Health. 2010;41(Suppl 3):1–14.
- Azuma K, Hayashi T, Yoshikawa H, et al. Development of a PCR-based method for detection of Toxocara canis DNA in humans. J Clin Microbiol. 2005;43(11):5296–300.
- Schantz PM. Toxocara larva migrans now. Am J Trop Med Hyg. 1989;41(3 Suppl):21–34.
- Pinelli E, Brandes S, Dormans J, Gremmer E, Van Loveren H. Infection with Toxocara canis leads to exacerbation of experimental allergic airway inflammation. Clin Exp Allergy. 2008;38(4):649–58.
